KOPRAN
|
The Current P/B Ratio of KOPRAN is 1.83.
| Share Price | ₹200.2 | Aug 20,2026 |
| Market Cap | ₹967.0 Cr | |
| Book Value | ₹528.9 Cr | Mar2026 - Consolidated Results |
| Price/Book | 1.83x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of KOPRAN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹967.0 Cr] as on Aug 20,2026
(/) Book Value [ ₹528.9 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 1.83x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.83 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of KOPRAN !
The chart below summarizes the trend in P/B Ratio of KOPRAN over the last five years.
Historical PB (Price/Book ) ratio chart of KOPRAN
PB Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.91x.
- KOPRAN 's operated at median p/b ratio of 1.64x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/b ratio peaked in Mar2022 at 3.19x.
- KOPRAN 's p/b ratio hit its five-year low in Mar2026 of 0.99x.
How does KOPRAN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| KOPRAN | 528.90 | 1.83 | 967.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.46 | 456,114.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 13.60 | 227,958.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.65 | 189,990.0 |
| CIPLA LTD | 34,369.40 | 3.38 | 116,141.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.61 | 98,604.4 |
| MANKIND PHARMA LTD | 16,252.60 | 6.06 | 98,499.5 |
| LUPIN LTD | 22,384.10 | 4.50 | 100,733.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.08 | 110,603.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.44 | 92,428.7 |
| LAURUS LABS LTD | 5,275.08 | 18.67 | 98,498.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs KOPRAN 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 1.83x |
| Max industry PB | 22.65x |
| Median industry PB | 4.50x |
| Average industry PB | 7.75x |
You may also like the below Video Courses